Towards the biomedical platform of Bergamo and Brescia - A possible course for the industrial districts evolution
The biomedical sector is more and more one of the main development assets for the western economies. Unlike other countries, Italy, also in this sector, doesn't have big multinational companies. Once again, the small and medium enterprises are the protagonists, with entrepreneurial histories that have made Mirandola biomedical district famous in all the world. However in the last years, also Bergamo and Brescia are interested in this new sector.
The event, promoted by the Local Committees of the two provinces, was the occasion to discuss a study that underlines how the majority of biomedical enterprises are advanced models of the previous industrial districts, that are a successful and competitive choice.
UniCredit Group, as a financial operator projected itself in global network but strongly linked to the local dimension, is very interest in this sector, potentially strategic for our country.
After the welcome of Roberto Sestini - Chairman of C.C.I.A.A. in Bergamo and of Edoardo Massaglia - Territorial Communities Relations UniCredit Group, the research "Exploration for a biomedical district in Bergamo-Brescia area" was presented by Riccardo Galli - Member of Bergamo-Brescia UniCredit Local Committees.
Then there was a round table "Toward the biomedical platform", coordinated by the Sociologist Aldo Bonomi, with the participation of: Aniello Aliberti - Chairman of Technix SpA; Sergio Barlati - Director of Biomedical and Biotechnological Science Department of Brescia University; Paolo Gazzaniga - Director of the Research Center of AssoBioMedica; Stefano Marcandelli - Chairman of Tecnobody Srl; Massimo Merlino - Lecturer of Management Engineering at Bergamo University; Luigi Teti - Chief Executive Officer of Markos Mefar SpA; Andrea Venturelli and Chairman of Invatec Srl.